Joelle Genevieve Johnson

Placeholder Person Graphic
Scientist I in the Virology and Microbiology
Joelle Genevieve Johnson is a Scientist I in the virology and microbiology group at MilliporeSigma. She graduated from Arizona State University with a BS in biochemistry. Previously, she worked in an evolutionary bioinformatics lab, focusing on genetics- and genomics-based approaches to analyze mutation patterns in ciliates and marmosets. She also took part in an internship at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, working in a structural glycobiology laboratory.

Related Articles

Figure 1: Batch manufacturing process vs. a low pH iVI process.
Technical
Continuous Process: Implementing Low pH Viral Inactivation in a Continuous Process

Viral inactivation (VI) is a critical step in ensuring the safety of monoclonal antibody (mAb), Fc fusion, and recombinant protein therapeutics and it is typically an important component of an overall virus control strategy for downstream biotherapeutic production processes. Considerations for successful implementation of an inline VI process are discussed in this article.